4-Chlorobenzyl bromide - CAS 622-95-7
Catalog: |
BB031511 |
Product Name: |
4-Chlorobenzyl bromide |
CAS: |
622-95-7 |
Synonyms: |
1-(bromomethyl)-4-chlorobenzene |
IUPAC Name: | 1-(bromomethyl)-4-chlorobenzene |
Description: | 4-Chlorobenzyl bromide (CAS# 622-95-7) is a useful reagent for the preparation of panicinotam derivatives for use as anti-inflammatory agents or immunomodulators. |
Molecular Weight: | 205.48 |
Molecular Formula: | C7H6BrCl |
Canonical SMILES: | C1=CC(=CC=C1CBr)Cl |
InChI: | InChI=1S/C7H6BrCl/c8-5-6-1-3-7(9)4-2-6/h1-4H,5H2 |
InChI Key: | KQNBRMUBPRGXSL-UHFFFAOYSA-N |
Boiling Point: | 107-108 °C / 8 mmHg |
Melting Point: | 48-50 °C |
Purity: | 95 % |
Density: | 1.57 g/cm3 |
Appearance: | White crystalline low melting solid |
MDL: | MFCD00040714 |
LogP: | 3.23490 |
GHS Hazard Statement: | H314 (100%): Causes severe skin burns and eye damage [Danger Skin corrosion/irritation] |
Precautionary Statement: | P260, P264, P280, P301+P330+P331, P303+P361+P353, P304+P340, P305+P351+P338, P310, P321, P363, P405, and P501 |
Signal Word: | Danger |
Publication Number | Title | Priority Date |
CN-111995567-A | Formamide pyridone iron chelator derivative with potential multi-target anti-AD activity and preparation method and application thereof | 20200724 |
CN-111662299-A | Substituted indolyazepinone compound and preparation method and application thereof | 20200710 |
CN-111620827-A | Novel allyl ether compound containing triazole as well as preparation method and application thereof | 20200605 |
CN-111620827-B | Allyl ether compound containing triazole and preparation method and application thereof | 20200605 |
CN-111518031-A | Hydroxamic acid-containing compound and preparation method and application thereof | 20200529 |
PMID | Publication Date | Title | Journal |
21579353 | 20100508 | 1-[2-(4-Chloro-benz-yloxy)-2-phenyl-ethyl]-1H-benzotriazole | Acta crystallographica. Section E, Structure reports online |
20151677 | 20100311 | Discovery of 4-amino-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidine-4-carboxamides as selective, orally active inhibitors of protein kinase B (Akt) | Journal of medicinal chemistry |
17971748 | 20060928 | Synthesis of new N-quaternary-3-benzamidoquinuclidinium salts | Molecules (Basel, Switzerland) |
Complexity: | 77 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 203.93414 |
Formal Charge: | 0 |
Heavy Atom Count: | 9 |
Hydrogen Bond Acceptor Count: | 0 |
Hydrogen Bond Donor Count: | 0 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 203.93414 |
Rotatable Bond Count: | 1 |
Topological Polar Surface Area: | 0 Å2 |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | 3.4 |
-
Catalog: BB025409
(1-Bromo-2,2,2-trifluoroethyl)benzene
Detail
-
Catalog: BB044157
(+)-2,10-(3,3-dichlorocamphorsultam)
Detail
-
Catalog: BB030539
(±)-2,3-Dibromobutane
Detail
-
Catalog: BB078021
(1-(3-Bromo-5-fluorophenyl)cyclopropyl)methanamine
Detail
-
Catalog: BB044156
(-)-2,10-(3,3-dichlorocamphorsultam)
Detail
-
Catalog: BB054256
((2S,4R)-2-((1H-1,2,4-Triazol-1-yl)methyl)-2-(2,4-dichlorophenyl)-1,3-dioxolan-4-yl)methanol
Detail
-
Catalog: BB079894
((3-Bromo-4-fluorophenyl)ethynyl)trimethylsilane
Detail
-
Catalog: BB030086
(1-Bromoethyl)benzene
Detail
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Halides
Customers Also Viewed
INDUSTRY LEADERS TRUST OUR PRODUCTS